{
  "nctId": "NCT05609760",
  "briefTitle": "Pictograms to Facilitate Comprehension of Medical Indications",
  "officialTitle": "Effects of an Automated System of Pictograms to Facilitate Comprehension of Medical Indications: A Randomised Trial",
  "protocolDocument": {
    "nctId": "NCT05609760",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2024-01-05",
    "uploadDate": "2024-01-05T14:21",
    "size": 267004,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT05609760/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "QUADRUPLE",
  "enrollmentInfo": {
    "enrollmentCount": 22,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2022-08-01",
    "completionDate": "2023-02-20",
    "primaryCompletionDate": "2023-02-20",
    "firstSubmitDate": "2022-09-06",
    "firstPostDate": "2022-11-08"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n* Adult patients aged 18 to 65 years with a recent diagnosis of bronchial asthma (\\<=15 days) based on 2018 Global Initiative For Asthma (GINA) criteria.\n* Diagnosis substantiated clinically and with consistent spirometry results as established by current GINA guidelines.\n* Patients who are to initiate bronchodilator treatment, including at least one inhaled corticosteroid and one short-acting bronchodilator.\n\nExclusion Criteria:\n\n* Patients presenting obstructive bronchial pathology other than bronchial asthma (chronic obstructive pulmonary disease, mixed states, etc.),\n* Patients who have participated in the pictogram design phase (Stage 1 of the project),\n* Patients with a diagnosis of dementia, diagnosis of harmful use of alcohol and other drugs according to the International Classification of Diseases (ICD-10).\n* Patients with significant ophthalmologic pathology that prevents the use of pictograms.\n* Patients who do not wish to participate in the project.",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "maximumAge": "65 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Disease Control at 60 Days",
        "description": "60 days after randomisation between groups using the Asthma Control Test (ACT). Min Score: 5 (indicating poor asthma control), Max Score 25 (indicating complete control). A score above 19 suggests well-controlled asthma.",
        "timeFrame": "60 days"
      },
      {
        "measure": "Disease Control at 30 Days",
        "description": "Asthma control achieved at 30 days after randomisation between groups using the Asthma Control Test (ACT).Min Score: 5 (indicating poor asthma control), Max Score 25 (indicating complete control). A score above 19 suggests well-controlled asthma.",
        "timeFrame": "30 days"
      },
      {
        "measure": "Disease Control at 7 Days",
        "description": "Asthma control achieved at 7 days after randomisation between groups using the Asthma Control Test (ACT). Min Score: 5 (indicating poor asthma control), Max Score 25 (indicating complete control). A score above 19 suggests well-controlled asthma.",
        "timeFrame": "7 days"
      }
    ],
    "secondary": [
      {
        "measure": "Inhaler Technique",
        "description": "Proper application of the inhaler technique.",
        "timeFrame": "60 days"
      },
      {
        "measure": "Patient Adherence to Inhaler Technique Steps at 60 Days",
        "description": "To assess patients' adherence to the correct inhaler technique, a five-step checklist was created, and a nurse evaluated each patient's inhalation technique. Then, the number of participants who correctly completed each individual step was reported.",
        "timeFrame": "60 days"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 3,
      "secondaryCount": 2,
      "otherCount": 0,
      "totalCount": 5
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": true,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 69,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:29:22.989Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}